Trials / Completed
CompletedNCT02747641
Prospective, Open-Label, Single-Center, Non-Comparative Study to Assess the Use of Pixel CO2 Laser System (FemiLift) in the Treatment of Vulvovaginal Atrophy (VVA) in Postmenopausal Female Subjects
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 15 (actual)
- Sponsor
- Alma Lasers Inc. · Industry
- Sex
- Female
- Age
- 35 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to assess the use of the Alma CO2 Pixel FemiLift™ in the treatment of VulvoVaginal Atrophy (VVA) in postmenopausal female subjects. The primary endpoint is to assess the change in the vaginal dryness by means of a Visual Analogic Scale (10 cm VAS) and/or Bachmann Index in VVA. The clinical improvement will be assessed by patient filled Vulvovaginal Atrophy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Pixel CO2 Laser System |
Timeline
- Start date
- 2016-05-01
- Primary completion
- 2016-12-01
- Completion
- 2017-08-01
- First posted
- 2016-04-22
- Last updated
- 2017-11-21
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02747641. Inclusion in this directory is not an endorsement.